KMT2D and neoplasm: Mechanistic studies with epigenetic and transcriptomic profiling showed that MLL4 promotes activation of both typical and super enhancers to increase the expression of their nearby genes, including the RISC component Ago2 and the DNA methyltransferases Dnmt1 and Dnmt3a in tumor cells.